Troriluzole : A new drug.

[Collinhucn]

biohavenpharma.com/science-...

[pinjem]

Page doesn't exist. What is it proposed to treat?

[Collinhucn in reply to pinjem]

Sorry about that. Please try this one:

clarahealth.com/studies/tro...

[Collinhucn in reply to pinjem]

This new drug claims to cure SCA (type 1, 2, 3, 7, or 10 )，Alzheimer's Disease，and some other neutral diseases. It is now in stage III in clinical trial.

[wobblybee]

🤔 This Trial is being conducted in the US, but has halted because of the current situation.

[Collinhucn in reply to wobblybee]

Thank you wobblybee. It is a new drug in the US that I bumped into the internet. I am sorry it has halted by Covid-19.

[Sunny8088 in reply to wobblybee]

Its going on , they ship it home, I am on it

[wobblybee in reply to Sunny8088]

👍🙂

For anyone interested see clinicaltrials.gov NCT03701399

[HarryB Administrator]

Dear all

Please note the recruitment of patients for this study is within the United States.

Harriet

[Collinhucn in reply to HarryB]

Thanks for pointting out.

[sonofapeter]

Not to be a negative Nancy, but this is the second time around for the same drug by this company. They simply rebranded it and changed the trial time to much longer. This was the results from the first trial with Trigriluzole and a link to individuals involved in the first study. biohavenpharma.com/investor...

livingwithataxia.org/t/bioh...

It's rather interesting I find that on a National Ataxia Foundation Facebook page, people involved in the second study with Troriluzole all seemed to suspect that they received the placebo. I just happened to point out that maybe, since they all seemed to think that they had received the placebo, it just doesn't work? Hoping not, but being realistic. I put my hopes more on gene therapy, like uniqure.com/gene-therapy/ca... or triplettx.com/.

God bless you all.

[Collinhucn in reply to sonofapeter]

Hi，sonofapeter：

Thank you for pointing out. Like you, I am more on gene therapy side.

[sonofapeter]

Interesting.......practicalneurology.com/news...